Breast cancer Genes

 It is estimated that one in eight women, or approximately 12%, will be diagnosed with breast cancer in her lifetime. However, women with certain genetic mutations have a higher lifetime risk of the disease. It’s estimated that 55 – 65% of women with the BRCA1 mutation will develop breast cancer before age 70. Approximately 45% of women with a BRCA2 mutation will develop breast cancer by age 70. Women with a BRCA1 or BRCA2 mutation who overcome their breast cancer with treatment appear to have a higher-than-average chance of developing a second cancer. This is called a recurrence. Cancers related to a BRCA1 mutation are also more likely to be triple negative breast cancer, which can be more aggressive and difficult to treat. You may find these statistics alarming. However, it’s important to note that less than 10% of women diagnosed with breast cancer have a BRCA mutation. Also, with early detection, the vast majority of breast cancer cases can be successfully treated—and that’s true even for people who have a BRCA1 or BRCA2 mutation.

 

    Related Conference of Breast cancer Genes

    September 25-26, 2025

    5th World Pathology Conference

    Amsterdam, Netherlands
    December 11-12, 2025

    6th International Conference on Breast Pathology and Cancer Diagnosis

    Amsterdam, Netherlands
    March 26-27, 2026

    24th Annual Pathology Congress

    Dubai, UAE
    June 22-23, 2026

    24th European Pathology Congress

    Paris, France

    Breast cancer Genes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in